Search

everythinglearnresearchcommunity

for

Search:↓

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.

Mutations in certain receptors can cause diseases and offer new treatment options.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

Androgens, male hormones, play a role in both men and women's health, and testosterone therapy can help women with low levels, but it's not suitable for pregnant or lactating women, or those with certain conditions.

Gene linked to common hair loss found, may lead to new treatments.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Looking at skin can help find and treat serious diseases early.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

Birth control pills can help reduce mild to moderate acne in women.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

We need better ways to test and understand SARMs to make safer and more effective treatments.

New treatments for PCOS focus on managing symptoms and improving fertility.

Androgens can cause hair growth in some areas but hair loss on the scalp.

The skin acts like an endocrine organ, making hormones that affect skin diseases and respond to stress.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.